The pharmacokinetic characteristics of desflurane, isoflurane and sevoflurane (16 patients for each anaesthetic) were estimated from measurements of inspired and end-expired agent concentrations and ventilation, obtained during routine anaesthesia in patients undergoing maxillofacial surgery (mean age 38 yr, duration of anaesthesia approximately 2 h). A twocompartment model described the data adequately. Although isoflurane and sevoflurane have almost the same tissue/blood partition coefficients, significant differences between substances were observed for the peripheral volume of distribution (medians and ranges: desflurane, 612 (343-1850) ml vapour kg bw -1 ; isoflurane, 4112 (1472-9396) ml vapour kg bw -1 ; sevoflurane, 1634 (762-8843) ml vapour kg bw -1 ) and the transport clearance from the central to the peripheral compartment (desflurane, 7.0 (4.4-11.1) ml vapour kg bw -1 min -1 ; isoflurane, 30.7 (15.9-38.7) ml vapour kg bw -1 min -1 ; sevoflurane, 13.0 (9.8-22.4) ml vapour kg bw -1 min -1 ). Thus, during clinical anaesthesia the important characteristics of the compounds could be obtained and compared between substances from simple data.
The ability to adjust inhalational anaesthesia is determined Different inhalational anaesthetics, however, have different effects, such as changes in cardiac output and regional by the pharmacokinetic features of the anaesthetic agent, blood flow. 8 9 These concentration-dependent effects 10 11 such as volumes of distribution and time constants. These may influence the uptake and distribution of the agent. variables depend on the physicochemical properties of the Such effects were suggested in the first published volunteer compounds and on cardiac output and the distribution of study of the wash-in pharmacokinetics of desflurane. 1 Simulblood flow. Published pharmacokinetic data for inhalation taneous administration of several volatile anaesthetics preagents have been obtained under controlled experimental vents measurement of the specific effects of each agent, 5 12 conditions in healthy volunteers. [1] [2] [3] [4] and extrapolation from such studies to clinical anaesthesia To reduce individual variation in pharmacokinetic behaviis questionable. our and allow comparisons between substances, Carpenter Additional differences between experimental and clinical and colleagues 4 5 gave a mixture of potent inhalational anaesthesia are that in clinical practice the inhalational anaesthetics (methoxyflurane, halothane, enflurane, isofluranaesthetic is washed into the patient's breathing system ane; totalling 1.1 MAC) in addition to an intravenous gradually, its concentration has to be adjusted to the stimulus anaesthetic. Thus, the pharmacokinetic behaviour of these during surgery, and the concentrations used are greater than four compounds, each by itself in subanaesthetic concentrathose used experimentally. tion, was measured simultaneously. The number of subjects
We set out to estimate and compare the pharmacokinetic needed in this design of study is small, and the design has parameters of the inhalational agents desflurane, isoflurane gained wide acceptance. With this method, desflurane was and sevoflurane during clinical anaesthesia, using a novel compared with halothane and isoflurane 6 in eight healthy method. 13 volunteers, and sevoflurane with isoflurane in seven. 7 In contrast to this procedure, inhalational anaesthesia in †This article is accompanied by Editorial I.
patients is carried out with a single volatile anaesthetic. thiopental 300-500 mg and succinylcholine 60-100 mg, the patient's trachea was intubated. Controlled ventilation peripheral compartment (V 2 ϭ Cl 12 d k 21 -1 ) and the steadywas then established and the volatile anaesthetic was given state volume (V ss ϭ V 1 ϩ V 2 ) were calculated. with nitrous oxide. Tidal volume (V T ) was set to 8 ml per
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The variables were characterized by their medians and kg body weight (bw), and normocapnia or mild hypocapnia ranges. To check whether baseline characteristics between was achieved by adjusting the respiratory rate (RR), usually treatment groups were similar, a comparison of physical between 10 and 12 breaths min -1 . Alveolar tidal volume characteristics of the patients and of the duration of anaesthe-(V T,alv ) was calculated as the measured tidal volume (V T ) sia was carried out using multiple analysis of variance corrected for dead space. 13 14 (MANOVA). An exploratory comparison of the pharmacoThe initial fresh gas flow (FGF) was set to 2 litres kinetic variables for desflurane, isoflurane and sevoflurane min -1 and was reduced to approximately 1 litre min -1 within was calculated using the Mann-Whitney U test and 95% the first 10 min. The initial vaporiser setting was 2-2. 5 confidence intervals based on the Hodges-Lehmann estimvol% for isoflurane and sevoflurane and 8-12 vol% for ator 15 (BIAS software). 16 Using the logarithmically transdesflurane. After approximately 10 min, an end-tidal concenformed values of the parameters the Hodges-Lehmann tration of 1.3 MAC for the respective inhalational anaesestimator comparies two random samples by calculating thetic in nitrous oxide was achieved. During the subsequent the median ratio of all combinations. If the resulting course of anaesthesia, fresh gas flow was further reduced 95% confidence interval includes unity, then no statistical and the concentrations of the volatile anaesthetic were difference between the samples exists. If 1.0 is encountered adjusted to the requirements of the surgery. (Sevoflurane is outside this interval, a difference is confirmed applying a approved by German authorities for use without fresh gas significance level of PϽ0.05. flow restrictions.) Towards the end of surgery, the fresh gas Additionally, analysis of covariance (ANCOVA) was concentration was usually reduced in a coasting phase, and used to check whether gender (nominal covariate), age, body subsequently the volatile anaesthetic and nitrous oxide were mass index and/or the duration of anaesthesia (continuous washed out with a high fresh gas flow of pure oxygen.
covariates) had an influence on the target pharmacokinetic Uptake was calculated as the difference between F I and variables V 1 , Cl 12 and k 21 in the whole data set (n ϭ 48).
As the inhalational anaesthetics were expected to differ in administered was calculated as the area under the uptake pharmacokinetic properties, the agent was included in the curve during the initiation and maintenance of anaesthesia; model as a nominal covariate. Assuming a factorial model, the dose eliminated at extubation was calculated as the logarithmically transformed values for pharmacokinetic negative area under the uptake curve during the washout parameters were used in the ANCOVA. Interactions between period. From these data the dose fraction remaining in the covariates supposed to affect pharmacokinetics were not body at extubation was calculated.
taken into account, since a sample of 48 was not large The individual concentration-time curves and the uptake enough to reliably test 10 two-fold and a number of higher were fitted to a two-compartment model as described. 13 interactions between covariates in addition to their main The target variables were the volume of distribution for the effect. The main question was whether the covariates had central compartment (V 1 ), the transport clearance from an effect on the pharmacokinetic parameters, and there was the central to the peripheral compartment (Cl 12 ) and the no a priori evidence that interactions between covariates microconstant for distribution from peripheral to central are important. The calculations were carried out using SPSS compartment (k 21 ). Based on end-expired concentrations 7.5, module General Multivariate (SPSS Inc., Chicago, and on the uptake, the parameters were adjusted in an IL, USA). additive variance model so that the calculated end-tidal concentration would correspond as closely as possible to
Results
the measured concentration (least-squares method). 13 From these estimates of the target pharmacokinetic parameters, Table 1 gives the characteristics of the patients and the the microconstant for distribution from central to peripheral duration of anaesthesia in the patients. There were no statistically significant differences between the groups (k 12 
, the volume of distribution of the The uptake (shaded area) depends on the difference F I -F E Ј and alveolar ventilation. Uptake during absorption (F I ϾF E Ј) corresponds to the dose administered and uptake during elimination (F I ϽF E Ј) to the dose eliminated. Initially, there were two rapid concentration changes. The second was carried out at 1 litre min -1 fresh gas flow (FGF), setting the vaporiser to 18. In steady-state uptake, absorption was in the same range as that during anaesthesia with isoflurane in Figure 2 , but showed a slight decrease with time. In comparison with the isoflurane and sevoflurane anaesthesia shown in Figures 2 and 3 respectively, the long coasting period (vaporiser set to 0) (between 130 and 175 min) and the larger negative component of the uptake curve are noteworthy. Elimination occurred even during coasting. The wash-out period at 3 L FGF until extubation took 12 min.
Fig 2
Concentration-time plots (F I , F E Ј) and uptake measured at the tube-connector during approximately 3 h of inhalation anaesthesia with isoflurane in a representative individual. The uptake (shaded area) during absorption (F I ϾF E Ј) corresponds to the dose administered and uptake during elimination to the dose eliminated via the lungs. After the initial 30 min, the uptake remained largely constant. The coasting phase under minimal flow conditions (130-145 min) was markedly shorter than in Figure 1 , and during coasting F I was still greater or equal to F E Ј, indicating that distribution from the central into the peripheral compartment caused a faster F E Ј decrease than anaesthetic elimination from the circle under minimal flow conditions. The wash-out phase at 3 L FGF until extubation was Ͼ30 min, and was longer than for desflurane and sevoflurane anaesthesia in Figures 1 and 3 respectively.
(MANOVA), but the mean duration of anaesthesia in F I and F E Ј declined faster for sevoflurane than for isoflurane but most rapidly with desflurane. The absolute uptake was patients receiving isoflurane was approximately 30% longer than that for the other anaesthetics.
smallest with sevoflurane, but in proportion to F E Ј this was about twice as great as the uptake of desflurane. Table 2 shows the values for the administered, eliminated and residual doses as calculated from the uptake. Although the resulting uptake or elimination during anaesthesia with desflurane ( Fig. 1), isoflurane (Fig. 2) and sevoflurane the inspired concentration was much greater for desflurane than for isoflurane, the median of the administered dose (Fig. 3) . Saturation occurred most rapidly with desflurane, shown by the small difference between F I and F E Ј. The was only 50% greater. Compared with the administered dose, the median quantity exhaled via the lungs by the time greater elimination of the compound is shown by the greater proportion of the negative area between the uptake curve of extubation was 24% for desflurane and about 10% for isoflurane and sevoflurane. and the abscissa. Sevoflurane had an intermediate position between desflurane and isoflurane. The gradient between
The pharmacokinetic features of the three compounds , F E Ј) and uptake measured at the tube-connector during 3 h of inhalation anaesthesia with sevoflurane in a representative individual. The uptake (shaded area) during absorption (F I ϾF E Ј) corresponds to the dose administered, and the uptake during elimination (F I ϽF E Ј) to the dose eliminated via the lungs. Absolute uptake during steady state was lowest with sevoflurane, but in relation to the end-tidal concentration it was twice as high as that of desflurane. Coasting was shorter than with desflurane ( Fig. 1) while uptake was zero, indicating that distribution into the peripheral compartment was as fast as anaesthetic elimination from the circle under minimal flow conditions. The duration of the wash-out phase at 3 L FGF until extubation was similar to that with desflurane anaesthesia in Figure 1 . difference in pharmacokinetic characteristics of the compounds exceeded those in the respective tissue/blood partition coefficients. could be described adequately in all patients using a twocompartment model, 13 which is therefore used in all further consideration of the compounds. Since only 50% of the Discussion profiles permitted an adequate fit to a three-compartment
The determination of the pharmacokinetic profiles of inhalamodel, the latter was discarded for this evaluation. The tional anaesthetics using respiratory gas analysis is an estimates of pharmacokinetic parameters are shown in Table  established method. 4-7 18 The analytical procedures for 3. For comparison between the compounds, Table 4 gives volatile anaesthetics described in the literature depend the ratios of the respective parameters between the agents primarily on gas chromatography assays, which permit the and 95% confidence intervals calculated using the Hodgesdetermination of concentrations over several orders of Lehmann estimator. Significant differences are marked with magnitude. This high sensitivity is required particularly for an asterisk.
the determination of minute concentrations several days The microconstants k 12 , describing distribution from the after exposure. central (1) into the peripheral (2) compartment, and k 21 ,
In this study, we used those data which are now routinely describing the redistribution and the corresponding transport available from anaesthetic workstations. As described in clearance (Cl 12 ), show that isoflurane and sevoflurane are the accompanying paper, 13 the data gathered during routine distributed into the peripheral compartment faster than monitoring, i.e. F I , F E Ј and ventilatory parameters, are desflurane. For desflurane the equilibrium constant k 12 /k 21 sufficient to provide reliable estimates of the pharmacoshowed a more pronounced balance towards redistribution kinetic parameters. This allowed the compounds to be than for the other compounds. The ratios differed from characterised under clinical conditions. Although the estimthose of k 12 , as the equilibrium constant is influenced ates were derived from and therefore are valid for the by k 21 . The microconstants obtained for sevoflurane and duration of anaesthesia, it remains to be investigated to isoflurane did not differ. what extent they also apply to the time after extubation, Using ANCOVA, the covariates tested explained jointly 77%, 87% and 50% of the overall variability for V 1 , Cl 12 , and how long anaesthesia must be maintained until the Table 3 Absolute values for the estimated pharmacokinetic variables and extrapolated parameters. Values are median (range). k 12 ϭ microconstant for transport from central to peripheral compartment; k 21 ϭ microconstant peripheral to central compartment; Cl 12 ϭ transport clearance from central to peripheral compartment; V 1 ϭ volume of distribution of the central compartment; V 2 ϭ volume of distribution of the peripheral compartment; V ss ϭ total volume of distribution during steady state. V 1 , V 2 and V ss are given as millilitres of inhaled anaesthetic in relation to body weight. Group differences are given in Table 4 Table 4 Comparison of the pharmacokinetic parameters between anaesthetics. Table 6 To relate estimated pharmacokinetic parameters to physicochemical characteristics, the ratios between substances for the tissue/gas and tissue/blood The ratios isoflurane/desflurane, sevoflurane/desflurane, isoflurane/sevoflurane and their 95% confidence intervals (CI) were calculated using the Hodgesequilibrium partition coefficients were calculated from published data. 17 Values for V 2 and Cl 12 obtained in this study, depending largely upon tissue/blood Lehmann estimator. *Significant group differences at PϽ0.05. For explanation of pharmacokinetic parameters, see legend to Table 3 partition coefficients, are included to facilitate comparison. All estimated ratios for pharmacokinetic parameters (see also (Table 5 ).
influencing variable to overall variation. For abbreviations, see legend to Table 3 It may be that k 21 reflects the effect of a third compartment
Influencing variable
Mean resulting difference (factor) which has increasing relevance as the duration of anaesthesia increases. Minor differences in baseline characteristics confirming the less extensive distribution of desflurane. This could be a disadvantage for isoflurane with respect to the control of the anaesthesia, because pronounced information gathered will allow reliable prediction of concentrations in the further course of anaesthesia. distribution into peripheral compartments causes a continuous large uptake and thus slower saturation of the central Apparent volumes of distribution were clearly smaller for desflurane than for sevoflurane and isoflurane (Tables 3 compartment. In contrast, the slower distribution of desflurane (small Cl 12 ) supports the more rapid saturation of the and 4). This was most pronounced for the peripheral volume. Distribution from the central to the peripheral compartment central compartment. The specific distribution behaviour thus turns out to be a relevant parameter besides the was much more rapid for isoflurane than for sevoflurane and was slowest for desflurane, whereas the redistribution concentration of agent, cardiac output and physicochemical properties, including solubility in blood, which determine (k 21 ) was only slightly greater for desflurane and sevoflurane than for isoflurane, and not significantly so. This minor the wash-in behaviour and the intraoperative control of an inhalational anaesthetic. Cl 12 of sevoflurane is two times difference may be explained by a 30% longer mean duration of isoflurane anaesthesia ( Table 1) . Duration of anaesthesia that of desflurane. Its uptake with respect to the endtidal concentration was about twice as high than that of significantly decreased the apparent k 21 and, to a lesser desflurane. High uptake and high clearance into the peri-the micro-and macrocirculation suggest that pharmacokinetic data from this type of volunteer experiment may phery become important in the control of 'Low and Minimal Flow' anaesthesia, in which, compared with high-flow differ from those obtained clinically.
Comparison of the volumes of distribution from our data applications, the capacity for agent delivery is close to the uptake by the patient (determined by the concentration with those from Yasuda and colleagues, 6 7 derived from the simultaneous application of inhaled anaesthetics, is possible range of the vaporiser and fresh gas flow: 1 litre min -1 in low-flow and 0.5 litre min -1 in minimal-flow applications). only to a limited extent as the models applied in the studies are different. Yasuda and colleagues 6 7 found for halothane, Because of limited agent delivery in these circumstances, rapid distribution to the periphery considerably reduces isoflurane, desflurane and sevoflurane almost equal tissue blood flows and tissue volumes, indicating that the size of the velocity of the concentration changes in the central compartment and makes it difficult to increase the depth of the virtual volumes of distribution varies according to the partition coefficients. This pattern of distribution relates to anaesthesia by increasing anaesthetic concentrations. In recovery, our data indicate that, during the wash-out period a time point when all redistribution processes were in steady state or when the compounds under investigation were until extubation, pulmonary elimination of isoflurane and sevoflurane is less than that of desflurane ( Table 2) . distributed and redistributed under almost identical conditions. The observation time between intubation and extubation was insufficient to give a valid fit to a model with more
For the time between intubation and extubation, our data suggest that the observed differences between the volumes than two compartments in 50% of the cases. In none of the patients could more than three compartments be fitted of distribution are not fully explained by differences in the partition coefficients of the compounds ( Table 6 ). The reliably. 4 However, a fourth and even a fifth compartment have been described in other studies [5] [6] [7] with measurements peripheral volume of distribution for isoflurane is more than 6 times and that of sevoflurane more than 2 times for 5-9 days after experimental anaesthesia. Over this timespan, ventilation has been assumed to correspond to that greater than that of desflurane (Table 4 ). There is no tissue for which a difference in partition coefficient of that seen in normal activity of the persons under investigation. How complex a model is needed to 'correctly' describe the magnitude has been described. Therefore, differences in blood flow distribution must be considered. For isoflurane, pharmacokinetics of an inhalational anaesthetic and how realistic are the underlying assumptions? 19 20 This depends it appears that during anaesthesia a pronounced redistribution of blood flow occurs into organs with large storage on the context of the question which is to be addressed by means of the model. Hypotheses about the proportion of a capacity. For sevoflurane this effect seems to be less pronounced. This assumption is supported by the data for compound remaining in the body and possible subsequent metabolism may require complex multicompartment the transport clearance Cl 12 , the most stable parameter, 13 which is more than 4 times greater for isoflurane and about models. A precise allocation of several hypothetical peripheral compartments to anatomical defined tissues, however, 2 times greater for sevoflurane than for desflurane, yet it should be only 1.5-fold greater if only the tissue/blood is hardly feasible. In contrast, to describe the pharmacokinetics of inhaled anaesthetics during clinical anaesthesia partition coefficients are considered (Table 6) . Unexpectedly large peripheral volumes of distribution, which correspond in order to compare agents in clinical practice or to improve patient control, our simplified model appears sufficient. 13 to considerable uptake, have indeed been described for isoflurane during clinical anaesthesia. 4 The finding that The tables show marked variation in the pharmacokinetic parameters. To reduce this variation, the concept of simultan-isoflurane, even at concentrations around 1 MAC in oxygen, markedly increased the blood flow into muscle tissue in eous administration of potent inhalation anaesthetics was developed. 4 5 Using this method, the haemodynamic condi-humans 29 and in animal experiments might serve as an explanation. 10 Thus, the pharmacokinetic parameters of our tions and regional blood flow are identical for all compounds. 5 Any specific effects of the substances on these simple two-compartment model could provide a better description of intraoperative processes than the differences factors, which may in certain cases affect the kinetics and clinical features quite considerably, remain undetected by in tissue solubility 30 between desflurane and isoflurane.
Because of a slower distribution into a smaller V 2 this method. 12 The possibility that two simultaneously administered inhalation anaesthetics could mutually influ-for desflurane compared with isoflurane or sevoflurane, distribution processes should contribute only slightly to the ence their solubility appears negligible, 21 yet interactions with the metabolism of other substances and their plasma decrease in concentration in the central compartment after 2 h of anaesthesia with desflurane. However, recent reports protein binding have been described in vitro, 22-24 and specific plasma protein binding has been described at on anaesthetic uptake at constant end-tidal concentrations in closed systems describe, after an initial wash-in, a least for halothane. 25 Metabolic interactions between inhalational anaesthetics were demonstrated in animals after constant rather than a declining uptake of desflurane and isoflurane 31 32 in the first hour of anaesthesia. These results sequential administration, 26 27 but could not be confirmed in man during simultaneous administration. 28 Even so, are said to be in contrast 32 to the square root of time model of anaesthetic uptake of Lowe and Ernst 33 and the substance-specific effects of the higher clinical doses on inhaled anaesthetics in a clinical setting: evaluation of a method predictions derived from multicompartment models. 6 
